IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Apogee Therapeutics Inc (APGE)

CUSIP: 03770N101 | NYSE | Healthcare · Biotechnology | Mid Cap | 461 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AFairmount Funds Management LLC00.0%Fell below 5%Sep 3, 2026298,647 sh (Jun 30, 2026)
13D/AVhcp Management III, LLC00.0%

Institutional Holders — Q3 2026

IFP Advisors, Inc79
0.0% of portfolio›$10.7K
StyleTurnoverLocationFiled
IFP Advisors, Inc
79$10.7K0.0%GrowthLowTampa, FL2026-10-16
No shares held
Sep 3, 2026
Not yet in a 13F
13D/AFairmount Funds Management LLC0
0.0% of class · Sep 3, 2026Fell below 5%
298,647 sh (Jun 30, 2026)
13D/AVhcp Management III, LLC0
0.0% of class · Sep 3, 2026No shares held
Not yet in a 13F